CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -31.9% | 30,000 | -57.1% | 0.00% | – |
| Q2 2022 | $295,000 | -95.8% | 70,000 | -87.4% | 0.00% | -100.0% |
| Q4 2018 | $6,985,000 | -15.5% | 556,600 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,262,000 | -14.9% | 556,762 | -3.5% | 0.00% | -20.0% |
| Q2 2018 | $9,711,000 | -26.5% | 577,035 | +0.0% | 0.01% | -28.6% |
| Q1 2018 | $13,211,000 | -15.3% | 576,900 | -4.3% | 0.01% | 0.0% |
| Q4 2017 | $15,589,000 | +53.8% | 602,600 | -12.3% | 0.01% | +40.0% |
| Q3 2017 | $10,133,000 | +5.7% | 687,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $9,584,000 | -18.2% | 687,000 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $11,720,000 | +65.8% | 687,000 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $7,069,000 | +1.8% | 687,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,946,000 | -10.0% | 687,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $7,715,000 | -17.8% | 687,000 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $9,384,000 | -28.0% | 687,000 | 0.0% | 0.01% | -28.6% |
| Q4 2015 | $13,032,000 | +1.1% | 687,000 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $12,895,000 | +26.1% | 687,000 | 0.0% | 0.01% | +20.0% |
| Q2 2015 | $10,229,000 | -1.7% | 687,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,405,000 | +13.7% | 687,000 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $9,151,000 | +5.6% | 687,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $8,663,000 | +24.8% | 687,000 | 0.0% | 0.00% | +33.3% |
| Q2 2014 | $6,939,000 | -24.9% | 687,000 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $9,240,000 | – | 687,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |